49 studies found for:    Alkermes | United States
Show Display Options
Rank Status Study
1 Recruiting A Study of ALKS 3831 in Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Samidorphan (Low Dose);   Drug: Samidorphan (Medium Dose);   Drug: Samidorphan (High Dose);   Drug: Placebo;   Drug: Olanzapine
2 Completed A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil or ALKS 9070) in Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ALKS 9072;   Drug: Placebo
3 Recruiting A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Intervention: Drug: ALKS 5461
4 Recruiting A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study
Condition: Major Depressive Disorder
Interventions: Drug: High Dose ALKS 5461;   Drug: Low Dose ALKS 5461;   Drug: Placebo
5 Recruiting A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
Conditions: Schizophrenia;   Alcohol Use Disorder
Interventions: Drug: Samidorphan + olanzapine (ALKS 3831);   Drug: Placebo
6 Recruiting A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study
Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461;   Drug: Placebo
7 Completed A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461;   Drug: Placebo
8 Completed ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)
Condition: Opioid-induced Constipation
Interventions: Drug: RDC-1036 (ALKS 37);   Drug: Placebo
9 Enrolling by invitation An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low Dose;   Drug: ALKS 9072, High Dose
10 Recruiting A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low;   Drug: ALKS 9072, High
11 Completed
Has Results
ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals
Condition: Opiate Dependence
Intervention: Drug: Medisorb naltrexone 380 mg
12 Completed ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)
Condition: OIC
Interventions: Drug: ALKS 37;   Drug: Placebo
13 Completed ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)
Condition: Opioid-induced Constipation
Interventions: Drug: ALKS 37;   Drug: Placebo
14 Completed A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low dose;   Drug: ALKS 9072, Med dose;   Drug: ALKS 9072, High dose;   Drug: Placebo
15 Completed ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
Condition: Binge Eating Disorder
Interventions: Drug: RDC-0313 (ALKS 33);   Drug: Placebo
16 Completed ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine
Condition: Cocaine Abuse
Interventions: Drug: ALKS 33-BUP;   Drug: ALKS 33;   Drug: Placebo
17 Completed A Study of ALKS 5461 in Healthy Volunteers
Condition: Pharmacokinetics
Interventions: Drug: ALKS 5461;   Drug: Placebo
18 Enrolling by invitation A Long-Term Safety Study of ALKS 5461
Condition: Major Depressive Disorder
Intervention: Drug: ALKS 5461
19 Completed ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence
Condition: Alcohol Dependence
Interventions: Drug: ALKS33 (RDC-0313) (1 mg);   Drug: ALKS33 (RDC-0313) (2.5 mg);   Drug: ALKS33 (RDC-0313) (10 mg);   Drug: Placebo
20 Completed Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
Conditions: Diabetes Mellitus;   Asthma;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: injected insulin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years